Both are standard treatments for a diabetic plantar foot ulcer — but they heal at very different rates, and most US clinics default to the slower one. Here's how LAOSS podiatrists decide between full offloading and local wound care, and why timing matters more than almost anything else.
Close the wound before it becomes an emergency.
Diabetic plantar foot ulcers don't heal because of dressings. They heal because pressure stops hitting the wound. The single biggest determinant of whether an ulcer closes is how completely you can keep weight off it — and that's where these two approaches separate.
Total contact cast (TCC) is a custom-molded, full-leg fiberglass cast that redistributes weight from the plantar wound to the lower leg. It's not removable. You wear it 24 hours a day, you walk in it (carefully), and it gets changed and recast weekly by a podiatrist. Because you physically cannot take it off and step on the wound, plantar pressure at the ulcer drops by roughly 80–90%. That offloading is why TCC healing rates land at 80–90% by 12 weeks in published trials.
Local wound care is the catch-all term for the standard non-cast approach: weekly or biweekly debridement of dead tissue, moist wound dressings, infection management, and offloading via a removable walking boot, postoperative shoe, or felt padding. Healing rates are lower — typically 40–60% at 12 weeks — and the gap is almost entirely explained by compliance. Patients take the boot off to shower, sleep, drive, work, and walk around the house. Every barefoot step on the wound resets healing.
At LAOSS we use both. The question is rarely "TCC or local care?" in the abstract — it's whether your specific ulcer, vascular status, infection burden, body habitus, and life situation make TCC the right move now or local care the right move first.
Diabetic foot ulcers sit at the intersection of neuropathy, vascular disease, and pressure. This short video walks through the underlying foot biology that makes offloading the entire ballgame.
Animations licensed from ViewMedica · Swarm Interactive
Most diabetic plantar ulcers sit under a metatarsal head or the heel — exactly where pressure peaks during gait. Diabetic neuropathy removes the pain feedback that would normally make you limp or unload the area, so the patient walks normally on the wound, again and again, hundreds of times an hour. The dressing on top doesn't change that mechanical load. A TCC does — it physically redistributes weight to the calf, ankle shell, and cast walls so the ulcer site sees a fraction of the force. That mechanical change is what closes the wound.
There's no universal answer, but the decision breaks down along four axes: infection status, vascular status, offloading capacity, and patient circumstance.
Infection status. An actively infected ulcer — purulence, cellulitis, suspected deep abscess, or osteomyelitis — is not a TCC candidate. The cast hides the wound for a week at a time and we need eyes on an infection daily. Acute infection comes first: cultures, antibiotics, sometimes surgical drainage, occasionally debridement of infected bone. Once the infection is controlled, TCC becomes appropriate.
Vascular status. Healing requires blood flow. We check pulses, get an ankle-brachial index, and order vascular imaging when indicated. If you have significant peripheral arterial disease, no amount of offloading will heal the wound — you need vascular intervention first. Skipping that step is the most common reason a "non-healing ulcer" doesn't close.
Offloading capacity. Can the patient physically tolerate a TCC? Most can. Edge cases: severe COPD where the cast weight is a problem, profound balance issues where falls become a risk, end-stage renal disease with rapid fluid shifts that change cast fit week-to-week. For those patients, local care with the best removable offloading we can engineer is the right call.
Patient circumstance. Drivers (TCC on the right foot complicates driving), patients who work in water, patients who live alone with poor home support — all change the calculus. We talk through real life, not just the wound.
Most patients eventually see both approaches in some form. The order — and how early we escalate to TCC — is what changes outcomes most.
When the ulcer is uninfected, vascular supply is adequate, and the patient can tolerate the cast — TCC is the first move, not the last.
When TCC is unsafe, unfeasible, or premature — local care is where we start.
Both approaches are covered by virtually every commercial insurance plan, Medicare, and most Medi-Cal plans. Cost is almost never the deciding factor.
Total contact cast application and weekly recasting are well-established billable services. Cost to you is typically a specialist copay plus any cast supply share, depending on plan.
Debridement, dressings, and offloading footwear are standard diabetic foot care services. Most patients pay a specialist copay per visit.
Speed-to-closure matters because every week an ulcer is open is another week of infection risk. Here's the published healing trajectory for each approach.
Most uncomplicated plantar ulcers close within 6–12 weeks under TCC. Weekly recasting lets us see the wound on a predictable schedule and adjust the cast as edema and limb shape change.
Healing under local care is typically measured in months, not weeks. The variability comes from how well the patient actually stays off the wound between visits.
We won't oversell TCC, and we won't dismiss local wound care. Here's the honest read on the diabetic foot literature.
Decades of randomized trials and systematic reviews place TCC as the gold standard for offloading uncomplicated plantar diabetic foot ulcers.
Debridement, dressings, and infection management are foundational — they make TCC work. Used alone with removable offloading, results lag.
These checklists are a starting point. The final call comes at your evaluation, with the ulcer in front of us and imaging in hand.
TCC is the first-line move when the ulcer is uninfected, vascular supply is adequate, and you can tolerate full-leg immobilization.
Local wound care is the right starting point when TCC is unsafe, unfeasible, or contraindicated for medical or social reasons.
Both approaches are active, ongoing programs — not single procedures. The cadence of in-office visits is what makes either one work.
First visit covers wound debridement, vascular and infection screen, imaging when indicated, and cast application. You leave that day in the cast.
Every week the cast comes off, the wound is debrided and photographed, and a fresh cast is applied. The visit anchors the whole healing process.
Local wound care runs on a weekly or biweekly schedule. The bottleneck is what happens between visits — every step on the wound resets healing.
These approaches aren't really opposites — TCC includes local wound care. Every TCC visit starts with the same sharp debridement, infection check, and dressing the local-care patient gets. The difference is what happens after: the cast goes back on, and the wound gets seven days of consistent offloading instead of seven days of whatever the patient can manage at home.
A common LAOSS pattern: start with 2–4 weeks of local wound care while we sort out infection control, vascular status, and edema. Once those are stable and the wound bed is clean, transition to TCC for the actual healing phase. After the ulcer closes, transition back to custom diabetic footwear, periodic debridement, and surveillance — because the single biggest risk factor for a future ulcer is a previous ulcer.
And there are situations where the answer is neither yet — for example, an ulcer with deep infection or suspected osteomyelitis needs vascular and infectious-disease management first, not faster offloading. We'll tell you that too. The goal is closing the wound safely, not racing to a particular technique.
Both approaches are well-tolerated when delivered by experienced specialists — but the risk profiles are different and worth understanding before you commit.
TCC risks come almost entirely from the cast itself — fit problems, skin issues at pressure points, and the practical impact of full-leg immobilization.
Local care risks are mostly about what doesn't happen — slower healing, longer infection window, and the cumulative cost of months in a removable boot.
Diabetic foot care at LAOSS is led by board-certified podiatric foot & ankle specialists who treat plantar ulcers every week. Drs. Matt Cikra, Danny Wang, Michael Marcus, and Yixi Lu apply and recast TCCs in-office and run the local wound care side too — debridement, infection control, vascular coordination, and the full range of advanced dressings and skin substitutes when indicated. The same podiatrist sees you week to week, which is exactly how diabetic foot care should work.
We coordinate closely with endocrinology, vascular surgery, and infectious disease as cases require. For high-risk anatomy or repeat ulcers, we also fit custom diabetic footwear and orthotics to prevent the next wound, not just close this one.
I had a foot ulcer for months with another clinic doing dressings every week and nothing was healing. LAOSS put me in a total contact cast and the wound closed in about ten weeks. Wish I'd come here sooner.
Book a visit at any of our Los Angeles-area offices. We'll evaluate the ulcer, check vascular flow, image when indicated, and tell you straight whether TCC, local wound care, or a combination is the right next step.
